Original Article Aldehyde dehydrogenase 1 expression correlates with clinicopathologic features of patients with breast cancer: a meta-analysis
暂无分享,去创建一个
[1] W. Woodward,et al. Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining. , 2014, Clinical breast cancer.
[2] Chung-Han Lee,et al. Clinicopathologic Characteristics of Breast Cancer Stem Cells Identified on the Basis of Aldehyde Dehydrogenase 1 Expression , 2014, Journal of breast cancer.
[3] M. Schneider-Kolsky,et al. Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer , 2014, Breast Cancer Research.
[4] Q. Sun,et al. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype , 2014, Medical Oncology.
[5] O. Woo,et al. Association of aldehyde dehydrogenase 1 expression and biologically aggressive features in breast cancer. , 2014, Neoplasma.
[6] S. Noguchi,et al. Clinicopathological Analysis of Breast Ductal Carcinoma in situ with ALDH1-Positive Cancer Stem Cells , 2013, Oncology.
[7] J. Akiba,et al. Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line , 2013, PloS one.
[8] N. Xu,et al. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis. , 2013, Pathology, research and practice.
[9] Q. Sun,et al. Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse , 2013, Cancer Cell International.
[10] Wei Zhang,et al. An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy. , 2013, International journal of clinical and experimental pathology.
[11] L. Newman,et al. Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women , 2013, Cancer.
[12] K. Yao,et al. Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma , 2013, Virchows Archiv.
[13] M. Miyazaki,et al. Aldehyde dehydrogenase 1‐positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node‐positive breast cancer , 2012, Cancer.
[14] M. Asadi-lari,et al. High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[15] R. Rocha,et al. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers , 2012, Pathology.
[16] A. D. de Craen,et al. Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer , 2012, BMC Cancer.
[17] Hirokuni Ikeda,et al. Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1–3 lymph node metastases , 2012, Breast Cancer.
[18] A. Tanimoto,et al. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple‐negative breast cancer , 2011, Histopathology.
[19] M. Sabel,et al. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development , 2011, Modern Pathology.
[20] Jae Hyun Kim,et al. An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer , 2011, British Journal of Cancer.
[21] A. Tanimoto,et al. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node‐positive breast cancers: a long‐term follow‐up study , 2011, Histopathology.
[22] Jorge S. Reis-Filho,et al. Histological types of breast cancer: How special are they? , 2010, Molecular oncology.
[23] Ling Zhou,et al. Prognostic relevance of ALDH1 in breast cancer: a clinicopathological study of 96 cases , 2010 .
[24] L. Akslen,et al. Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer , 2009, British Journal of Cancer.
[25] J. Reis-Filho,et al. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment , 2010, Breast Cancer Research and Treatment.
[26] F. Bertucci,et al. Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer , 2009, Clinical Cancer Research.
[27] David A Hess,et al. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability , 2009, Journal of cellular and molecular medicine.
[28] T. Taguchi,et al. Stem cell marker aldehyde dehydrogenase 1‐positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression , 2009, Cancer science.
[29] Tao Zhang,et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. , 2009, Cancer research.
[30] R. Dhir,et al. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. , 2007, Cancer research.
[31] J. Krieger,et al. Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias , 2007, Journal of hypertension.